SWEAT EATING BACTERIA MAY IMPROVE SKIN HEALTH
Bacteria that
metabolize ammonia, a major component of sweat, may improve skin health and
some day could be used for the treatment of skin disorders, such as acne or
chronic wounds. In a study conducted by AOBiome LLC, human volunteers using the
bacteria reported better skin condition and appearance compared with a placebo
control group. The researchers presented the study results at the 5th ASM
Conference on Beneficial Microbes in Washington, DC
Ammonia-oxidizing
bacteria (AOB) are ubiquitous in soil and water and are essential components of
the nitrogen cycle and environmental nitrification processes. The researchers
hypothesized that AOB are uniquely suited for the environment of the human skin
because ammonia oxidation products, nitrite and nitric oxide, play important
roles in physiological functions of the skin, including inflammation, blood
vessel relaxation and wound healing. AOB may also improve the skin
microenvironment by driving a lower pH through ammonia consumption.
For the study, the
researchers used a strain of Nitrosomonas eutropha isolated from organic soil samples. In
the blinded, placebo-controlled, study involving 24 volunteers, one group
applied a suspension of the live bacteria on their face and scalp for one week,
while a second group used placebo. Both groups were followed for an additional
two weeks. Subjects did not use hair products during the first and second week
and they returned to their normal routine for the third week.
The AOB users
reported qualitative improvements in skin condition compared with no or minimal
improvement reported by the control group. Use of a bacterial DNA detection
assay demonstrated the presence of AOB in 83-100 percent of skin swabs obtained
from AOB users during or immediately after completion of the one-week
application period, and in 60 percent of the users on Day 14, but not in any of
the placebo control samples. Surprisingly, in this small study, the improvement
among the AOB users correlated with the levels of AOB on their skin. Neither
group had AOB on their skin at the start of the study. Further analysis
suggested potential modulation of the skin microbiota by AOB. Importantly,
there were no adverse events associated with the topical application of AOB.
"This study
shows that live Nitrosomonas are well tolerated and may hold
promise as novel, self-regulating topical delivery agents of nitrite and nitric
oxide to the human skin," said Dr. Larry Weiss, AOBiome's Chief Medical
Officer. "Our next step is to conduct clinical trials to assess the
therapeutic potential of AOB in patients with acne or diabetic ulcers."
Comments
Post a Comment